Immunoglobulin A nephropathy (also known as IgA nephropathy or Berger's disease) is a condition that causes IgA antibodies to accumulate in the kidneys—leading to damage that affects their blood ...

National Health Service: “IgA Nephropathy.” Mayo Clinic: “IgA nephropathy (Berger's disease).” Clinical Journal of the American Society of Nephrology: “Recurrence of IgA Nephropathy ...

Panelists discuss how patients with immunoglobulin A (IgA) nephropathy typically present with microscopic or gross hematuria, often during upper respiratory infections, along with variable proteinuria ...

The biopsy showed that Miller had IgA nephropathy, which was difficult news to receive. “It changed my life quite a bit, as you can imagine, getting a diagnosis for a rare disease that there’s ...

Edgar Lerma, MD, provides insights into the pathophysiology of IgA nephropathy (IgAN) and the therapeutic promise of targeting APRIL.

Magistroni et al. retrospectively reviewed 237 IgA nephropathy cases diagnosed from 1981 to 2004 to identify indicators of disease progression that might help to guide treatment. Multivariate ...

Astrasentan becomes the first and only endothelin A receptor antagonist to focus on proteinuria reduction in primary ...

The Food and Drug Administration (FDA) has granted accelerated approval to Vanrafia ® (atrasentan) to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk of rapid ...

Adults recently diagnosed with immunoglobulin A nephropathy who were assigned sparsentan as first-line therapy experienced rapid and sustained reductions in proteinuria, according to ...

Immunoglobulin A (IgA) nephropathy, also called Berger’s disease, is an autoimmune disease that affects your kidneys. IgA is an antibody. Antibodies are proteins made by your immune system.

PhD Immunoglobulin A nephropathy (known as IgA nephropathy or Berger's disease) is a rare kidney disease that occurs when the body's immune system response causes IgA antibodies to build up in the ...